|
Animal models of human disease
Citations 31-40 of 40 total displayed.
|
Past content
(since May 2008):
|
- Original Article
Prevention of Myofilament Dysfunction by Beta-blocker Therapy in Post-infarct Remodeling
- Dirk J. Duncker, Nicky M. Boontje, Daphne Merkus, Amanda Versteilen, Judith Krysiak, Giulia Mearini, Ali El-Armouche, Vincent J. de Beer, Jos M.J. Lamers, Lucie Carrier, Lori A. Walker, Wolfgang A. Linke, Ger J.M. Stienen, and Jolanda van der Velden
Circ Heart Fail published March 25, 2009, doi:10.1161/CIRCHEARTFAILURE.108.806125
[Abstract]
- Original Articles
Pheochromocytoma-Induced Cardiomyopathy is Modulated by the Synergistic Effects of Cell-Secreted Factors
- Hector R. Mobine, Aaron B. Baker, Libin Wang, Hiroko Wakimoto, Kurt C. Jacobsen, Christine E. Seidman, J.G. Seidman, and Elazer R. Edelman
Circ Heart Fail 2009;2:121-128; published online before print as doi:10.1161/CIRCHEARTFAILURE.108.813261
[Abstract]
[Full text]
- Original Article
Inhibition of PKC-β by Ruboxistaurin Preserves Cardiac Function and Reduces Extra-Cellular Matrix Production in Diabetic Cardiomyopathy
- Kim A. Connelly, Darren J. Kelly, Yuan Zhang, David L. Prior, Andrew Advani, Alison J. Cox, Kerri Thai, Henry Krum, and Richard E. Gilbert
Circ Heart Fail published February 10, 2009, doi:10.1161/CIRCHEARTFAILURE.108.765750
[Abstract]
- Original Article
Pheochromocytoma-Induced Cardiomyopathy is Modulated by the Synergistic Effects of Cell-Secreted Factors
- Hector R. Mobine, Aaron B. Baker, Libin Wang, Hiroko Wakimoto, Kurt C. Jacobsen, Christine E. Seidman, Jonathan G. Seidman, and Elazer R. Edelman
Circ Heart Fail published February 10, 2009, doi:10.1161/CIRCHEARTFAILURE.108.813261
[Abstract]
- Original Articles
Comparative Study of Vasodilators in an Animal Model of Chronic Volume Overload Caused by Severe Aortic Regurgitation
- Eric Plante, Dominic Lachance, Jonathan Beaudoin, Serge Champetier, Élise Roussel, Marie Arsenault, and Jacques Couet
Circ Heart Fail 2009;2:25-32, doi:10.1161/CIRCHEARTFAILURE.108.801548
[Abstract]
[Full text]
- Editorials
GLP-1 Therapy: Beyond Glucose Control
- Derek J. Hausenloy and Derek M. Yellon
Circ Heart Fail 2008;1:147-149, doi:10.1161/CIRCHEARTFAILURE.108.810887
[Full text]
- Original Articles
Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure–Prone Rat
- Indu Poornima, Suzanne B. Brown, Siva Bhashyam, Pratik Parikh, Hakki Bolukoglu, and Richard P. Shannon
Circ Heart Fail 2008;1:153-160; published online before print as doi:10.1161/CIRCHEARTFAILURE.108.766402
[Abstract]
[Full text]
- Original Article
Chronic Glucagon-like Peptide-1 (GLP-1) Infusion Sustains LV Systolic Function and Prolongs Survival in the Spontaneously Hypertensive-Heart Failure Prone Rat
- Indu Poornima, Suzanne Brown, Siva Bhashyam, Pratik Parikh, Hakki Bolukoglu, and Richard Patrick Shannon
Circ Heart Fail published July 14, 2008, doi:10.1161/CIRCHEARTFAILURE.108.766402
[Abstract]
- Original Articles
Hemodynamic, Hormonal, and Renal Actions of Adrenomedullin 2 in Experimental Heart Failure
- Miriam T. Rademaker, Christopher J. Charles, M. Gary Nicholls, and A. Mark Richards
Circ Heart Fail 2008;1:134-142; published online before print as doi:10.1161/CIRCHEARTFAILURE.107.755504
[Abstract]
[Full text]
- Original Article
Hemodynamic, Hormonal and Renal Actions of Adrenomedullin 2 in Experimental Heart Failure
- Miriam T. Rademaker, Chris J. Charles, M. Gary Nicholls, and A. Mark Richards
Circ Heart Fail published May 28, 2008, doi:10.1161/CIRCHEARTFAILURE.107.755504
[Abstract]
|
|
